Based on various bioinformatics analyses such as network pharmacology, transcriptome difference analysis, single-cell sequencing analysis, and molecular docking, we initially obtained 13 core gene clusters in which DHIE affects breast cancer, and screened PLK1 as the target with the highest relevance, which may exert an inhibitory effect on cancer by blocking the cell cycle. The gene discussed is PLK1; the disease is breast carcinoma.